TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · major macro event coming up
VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

9.40$ -0.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow VCRE
Line item 2022 2023 2024 2025
– – – –
– -5.2% -34.5% -100.0%
– – – –
– -100.0% – –
– – +965.1% -166.7%
– – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?